129 related articles for article (PubMed ID: 2836153)
1. Enzyme activities of collagen peptidase (CP), monoaminoxidase (MAO) and N-acetyl-beta-D-glucosaminidase (beta-NAG) as fibrosis marker in chronic liver diseases.
Müller A; Zollmann C; Machnik G; Krombholz B; Reinhardt M; Jorke D
Dtsch Z Verdau Stoffwechselkr; 1988; 48(1):27-34. PubMed ID: 2836153
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of serum laminin P1, procollagen-III peptides, and N-acetyl-beta-glucosaminidase for monitoring the activity of liver fibrosis.
Schneider M; Voss B; Högemann B; Eberhardt G; Gerlach U
Hepatogastroenterology; 1989 Dec; 36(6):506-10. PubMed ID: 2693303
[TBL] [Abstract][Full Text] [Related]
3. [Clinical value of N-acetyl-beta-D-glucosaminidase and alpha-galactosidase in liver diseases].
Hempel A; Müller G; Hempel RD
Z Gesamte Inn Med; 1981 Jul; 36(13):457-9. PubMed ID: 6269308
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic potential of the combined determination of serum monoamine oxidase and N-acetyl-beta-D-glucosaminidase for fibroproliferative liver diseases.
Gressner AM; Roebruck P
J Clin Chem Clin Biochem; 1983 Jan; 21(1):19-23. PubMed ID: 6854216
[TBL] [Abstract][Full Text] [Related]
5. Predictive values of serum N-acetyl-beta-D-glucosaminidase for fibrotic liver disorders--correlation with monoamine oxidase activity.
Gressner AM; Roebruck P
Clin Chim Acta; 1982 Sep; 124(3):315-26. PubMed ID: 7127844
[No Abstract] [Full Text] [Related]
6. [Activity of beta-N-acetylglucosaminidase in chronic alcoholic liver disease].
Pinto C; Galvão-Teles A; Monteiro E; Marques C; Azevedo M; Manso C
Acta Med Port; 1990; 3(2):75-9. PubMed ID: 2349891
[TBL] [Abstract][Full Text] [Related]
7. [N-Acetyl-beta-glucosaminidase activity and hydroxyproline excretion in liver diseases in alcoholics].
Laskus T; Gruszecka H; Lupa E; Poplewska M; Babiuch L
Pol Tyg Lek; 1989 Jun; 44(24):573-4. PubMed ID: 2631075
[TBL] [Abstract][Full Text] [Related]
8. [Diagnostic value of five serum markers for liver fibrosis].
Luo R; Yang S; Xie J; Zhao Z; He Y; Yao J
Zhonghua Gan Zang Bing Za Zhi; 2001 Jun; 9(3):148-50. PubMed ID: 11412388
[TBL] [Abstract][Full Text] [Related]
9. [Clinical-chemical activity diagnosis in liver fibrosis].
Pott G; Schneider M; Ackermann W; Gerlach U
Med Welt; 1981 Jan; 32(3):75-8. PubMed ID: 7207134
[No Abstract] [Full Text] [Related]
10. [Progress in the diagnosis of chronic liver disease: diagnostic activity in liver fibrosis and cirrhosis].
Pott G; Gerlach U
Leber Magen Darm; 1982 Aug; 12(4):141-4. PubMed ID: 6752610
[TBL] [Abstract][Full Text] [Related]
11. [Correlation of morphometric parameters with enzyme-activities in cases of liver diseases with fibrosis (author's transl)].
Dahrenmöller N; Roessner A; Pott G; Müller KM
Microsc Acta Suppl; 1979; (3):191-6. PubMed ID: 295410
[TBL] [Abstract][Full Text] [Related]
12. [The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients].
Park JH; Park CK; Kim ES; Park SY; Jo CM; Tak WY; Kweon YO; Kim SK; Choi YW
Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):79-88. PubMed ID: 12824747
[TBL] [Abstract][Full Text] [Related]
13. [Determination of N-acetyl-glucosaminidase (NAG) in diabetic subjects].
Melosi A; Ricci F
Quad Sclavo Diagn; 1983 Mar; 19(1):113-20. PubMed ID: 6675040
[TBL] [Abstract][Full Text] [Related]
14. The effect of elective surgery on serum N-acetyl-beta-D-glucosaminidase activity.
Harju E; Ehrola P; Koivula T
Acta Physiol Hung; 1990; 76(3):237-43. PubMed ID: 2100103
[TBL] [Abstract][Full Text] [Related]
15. [Isoenzymes of serum N-acetyl-beta-D-glucosaminidase in insulin-dependent diabetic subjects].
Clemenzia G; Persichetti S; Sagliaschi G; Gallo G; Re M; Ronchi F; Russo G; Zappi P; Scibinetti F; Amici A
Minerva Med; 1988 Jul; 79(7):547-9. PubMed ID: 3405458
[TBL] [Abstract][Full Text] [Related]
16. Human neutrophil N-acetyl-beta-D-glucosaminidase: granule localization. Further evidence for two azurophil granules.
West BC; Dunphy CH; Moore CA
J Lab Clin Med; 1984 Jul; 104(1):60-8. PubMed ID: 6330250
[TBL] [Abstract][Full Text] [Related]
17. [N-acetyl-beta-D-glucosaminidase as an early marker and indicator of the extent of kidney and liver lesions in endotoxemia and endotoxic shock].
Martinović S; Filipović N; Hadzić N; Pikula B
Acta Med Iugosl; 1991; 45(2):111-21. PubMed ID: 1887806
[TBL] [Abstract][Full Text] [Related]
18. Serum concentration of procollagen-III-peptide in comparison with the serum activity of N-acetyl-beta-glucosaminidase for diagnosis of the activity of liver fibrosis in patients with chronic active liver diseases.
Ackermann W; Pott G; Voss B; Müller KM; Gerlach U
Clin Chim Acta; 1981 May; 112(3):365-9. PubMed ID: 7237835
[No Abstract] [Full Text] [Related]
19. The APRI may be enhanced by the use of the FIBROSpect II in the estimation of fibrosis in chronic hepatitis C.
Snyder N; Nguyen A; Gajula L; Soloway R; Xiao SY; Lau DT; Petersen J
Clin Chim Acta; 2007 Jun; 381(2):119-23. PubMed ID: 17442291
[TBL] [Abstract][Full Text] [Related]
20. [A quantitative study of the relationship between levels of liver fibrosis markers in sera and fibrosis stages of liver tissues of patients with chronic hepatic diseases].
Ding XJ; Li SB; Li SZ; Liu HS; Liu B; Xu FM; Gu RW
Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):911-4. PubMed ID: 16381637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
